Business & Economy · St. Louis ·
AstraZeneca acquires St. Louis vaccine startup Omniose
AstraZeneca said Tuesday it acquired Omniose, a St. Louis-based startup developing vaccines against bacterial infections, which becomes a wholly owned subsidiary.
1 report
Headline and summary written by the Acta Diurna desk using only what the outlets above reported. Read their reporting for the full story. How we stay neutral.
St. Louis news today · More Business & Economy · St. Louis prediction markets